INTEGRA LIFESCIENCES HOLDING

IART is the ticker symbol for Integra LifeSciences Holdings Corporation, a global medical technology company. The stock trades on the Nasdaq Global Select Market. IART represents ownership in a company that develops surgical instruments, regenerative medicine products, and orthopedic implants. Its shares are bought and sold by investors on public exchanges.

IART operates in the medical device industry, specifically within the healthcare sector. The company focuses on neurosurgery, reconstructive surgery, and regenerative medicine. It competes with other medical technology firms that produce surgical and orthopedic products. The industry is subject to FDA regulations and depends on hospital spending and clinical adoption.

Recent performance for IART can be found in the price chart and performance data on this page. Stock movements reflect market reactions to earnings, news, and sector trends. For the latest percentage changes and trends, refer to the live quotes and charts displayed above.

Determining whether IART is overvalued or undervalued requires comparing its current valuation multiples, such as P/E and EV/EBITDA, to its historical averages and peer group. These metrics are available on this page and in financial data providers. Valuation depends on growth expectations, profitability, and market conditions, so no single answer applies to all investors.

IART stock can be traded in pre-market and after-hours sessions through many brokerages that offer extended-hours trading. These sessions have lower liquidity and wider spreads than regular trading hours. Not all brokers support extended-hours trading for all stocks, so check with your broker for availability and any associated fees or restrictions.

Analyzing IART's financial performance involves reviewing its income statement, balance sheet, and cash flow statement. Key metrics include revenue growth, gross margin, operating margin, net income, and free cash flow. Investors often compare these figures across quarters and against competitors in the medical device industry. Earnings reports and SEC filings provide the most reliable data.